Close

Immunomedics (IMMU) Misses Q2 EPS by 1c

February 3, 2016 4:00 PM EST

Immunomedics (NASDAQ: IMMU) reported Q2 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.23 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings